Drug Profile
DTaP-hepatitis B vaccine - GSK
Alternative Names: Infanrix-HepBLatest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Bacterial vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diphtheria; Hepatitis B; Pertussis; Tetanus
Most Recent Events
- 25 Apr 2005 Withdrawn for Diphtheria in Italy (IM)
- 25 Apr 2005 Withdrawn for Diphtheria in Spain (IM)
- 25 Apr 2005 Withdrawn for Diphtheria in Sweden (IM)